64 results
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
5 Aug 20
Results of Operations and Financial Condition
4:10pm
in new diagnoses and chemotherapy patient starts because of the onging COVID-19 pandemic, the Company is maintaining its 2020 guidance for net product … pandemic and are maintaining our 2020 net product sales guidance of $70 million to $80 million.”
Financial Results
Net product sales for the three
8-K
EX-99.1
HRTX
Heron Therapeutics Inc
5 Nov 20
Results of Operations and Financial Condition
8:40am
Heron anticipates a decrease in new diagnoses and chemotherapy patient starts because of the ongoing COVID-19 pandemic (COVID-19), the Company has … of CINVANTI against a backdrop of arbitrage and the ongoing global pandemic. Based on the strong commercial execution, we are very pleased to increase
8-K
EX-99.1
y8omziwkl qubf7z8ef3
10 May 21
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
kiashh5r tkvr39
24 Feb 21
Results of Operations and Financial Condition
8:40am
8-K
EX-99.1
tl9m ai6d0ino
9 Aug 21
Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Recent Corporate Updates
8:10am
8-K
EX-99.1
z3kc195ya68ozba0z3
3 Nov 21
Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates
4:05pm
8-K
EX-99.1
qwmpn4i fqfos3msb
9 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
n82os
8 Sep 20
Heron Therapeutics Announces Successful Outcome of FDA Type A Meeting to Discuss HTX-011 for the Management of Postoperative Pain
8:41am
8-K
EX-99.1
ltjpo
24 Jul 23
Heron Therapeutics Announces $30 Million Private Placement Financing
9:12am
8-K
EX-99.1
h4imeo8e 3se
13 Nov 20
Heron Therapeutics Resubmits New Drug Application to FDA for HTX-011 for the Treatment of Postoperative Pain
8:40am
8-K
EX-99.1
slczsbz e8qs
18 Nov 21
Heron Therapeutics Announces Submission of HTX-019 NDA for the Prevention of Postoperative Nausea and Vomiting to FDA
7:40am
8-K
EX-99.1
n2jmhcvvgrv7n pvjs
17 Mar 22
Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
8:45am
8-K
EX-99.1
c7ien wpp9vwx
21 Jan 21
Heron Therapeutics Announces Publication of Results from EPOCH 1 Follow-On Study of HTX-011 in Patients Undergoing Bunionectomy Surgery
8:40am